Tumor chemosensitivity is correlated with expression of multidrug resistance associated factors in variously differentiated gastric carcinoma tissues

Hepato-Gastroenterology

Volumn 60, Issue 122, 2013, Pages 213-216

  Li, Yong ^a   Tan, Bi Bo ^a   Zhao, Qun ^a   Fan, Li Qiao ^a   Liu, Yü ^a   Hao, Ying Jie ^a   Zhao, Xüe Feng ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Chemosensitivity; Differentiation; Gastric carcinoma; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN DERIVATIVE; CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; EPIRUBICIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE P1; HYDROXYCAMPTOTHECIN; MULTIDRUG RESISTANCE PROTEIN; OXALIPLATIN; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CANCER TISSUE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS;

EID: 84877717087     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12535     Document Type: Article

References (21)

1. Liu W, Zhu J, Cao L, Rodgers GP: Expression of Hgc-1 is correlated with differentiation of gastric carcinoma. Histopathology 2007; 51:157-165.
2. Derwinger K, Kodeda K, Bexe-Lindskog E, Taflin H: Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer. Acta Oncol 2010; 49:57-62.
3. Patel PR, Yao JC, Hess K, Schnirer I, Rashid A, Ajani JA: Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer. Cancer 2007; 110:2186-2190.
4. Hsu PI, Hsieh HL, Lee J, et al.: Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Ann Surg Oncol 2009; 16:1686-1694.
5. Lyons JM 3rd, Abergel J, Thomson JL, et al.: in vitro chemoresistance testing in well-differentiated carcinoid tumors. Ann Surg Oncol 2009; 16:649-655.
6. Irmak Yazicioǧlu MB, Gencer S: Differential response of gastric carcinoma MKN-45 and 23132/87 cells to H2O2 exposure. Turk J Gastroenterol 2011; 22:145-151.
7. Wang CH, Zheng WB, Qiang O, Tang CW: Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line. J Dig Dis 2009; 10:91-98.
8. Wang J, Xia Y, Wang H, Hou Z: Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901. Integr Cancer Ther 2007; 6:400-404.
9. Huang L, Wang C, Zheng W, Liu R, Yang J, Tang C: Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein. Anticancer Drugs 2007; 18:1075-1080.
10. Houghton P, Fang R, Techatanawat I, Steventon G, Hylands PJ, Lee CC: The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods 2007; 42:377-387.
11. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K: Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S- transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Invest 2008; 26:344-351.
12. Li Y, Tan BB, Fan LQ, Zhao Q, Song ZC, Wang D: Proteomic identification and comparison of differentiation-related proteins in gastric carcinoma cell lines. Zhonghua Zhong Liu Za Zhi 2010; 32:179-184.
13. Han J, Tan BB, Geng W, Lu BR, Zhao JH: Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues. Ai Zheng 2008; 27:1166-1171.
14. Tan BB, Li Y, Han J, et al.: Relationship of cyclooxygenase-2 and multidrug resistance associated factors to chemosensitivities in gastrointestinal carcinomas. Sichuan Da Xue Xue Bao Yi Xue Ban 2010; 41:128-131.
15. Zhang D, Fan D: Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 2007; 7:1369-1378.
16. Kwon HC, Roh MS, Oh SY, et al.: Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase Pi for 5-fluorouracil/ oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol 2007; 18:504-509.
17. Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, Ooi A: Topoisomerase IIalpha gene amplification in gastric Carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. Hum Pathol 2006; 37:1333-1343.
18. Huang WT, Huang CC, Weng SW, Eng HL: Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK/T cell lymphoma: further exploring the role of P53 and WT1 gene. Pathology 2009; 41:127-132.
19. Guenova ML, Balatzenko GN, Nikolova VR, Spassov BV, Konstantinov SM: An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene. Hematology 2010; 15:135-143.
20. Li X, Hong L, Zhao Y, et al.: A new apoptosis inhibitor, CIA-PIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Biochem Cell Biol 2007; 85:741-750.
21. Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y: Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep 2010; 23:1469-1475.